PuSH - Publication Server of Helmholtz Zentrum München

Janka, H.U.* ; Ziegler, A.-G.* ; Standl, E.* ; Mehnert, H.*

Daily insulin dose as a predictor of macrovascular disease in insulin treated non-insulin-dependent diabetics.

Diabetic Med. 13, 359-364 (1987)
PMC
Open Access Green as soon as Postprint is submitted to ZB.
In the longitudinal Schwabing study, unselected insulin-treated diabetic patients were followed for major vascular complication (MVC) (stroke, myocardial infarction, gangrene) and asymptomatic, early detectable peripheral vascular disease (PVD). In the group of insulin-treated NIDDM multiple logistic regression analysis revealed the number of daily injected insulin units as a significant predictor for MVC and PVD (t = 1.98; p less than 0.04; x +/- S.D.: PVD yes 57.6 +/- 21.4 U/d; PVD no 44.3 +/- 17.7; age-adjusted univariate p less than 0.001). Daily insulin dose correlated highly significantly with serum triglycerides (r = 0.40, p less than 0.001) as well as with blood glucose (r = 0.33, p less than 0.001). These data suggest that insulin resistance is characteristic for atherosclerotic disease in NIDDM and the hyperinsulinemia-hypertriglyceridemia-syndrome might be a powerful cardiovascular risk factor in diabetes mellitus.
Impact Factor
Scopus SNIP
Altmetric
2.845
0.000
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Scientific Article
Language english
Publication Year 1987
HGF-reported in Year 0
ISSN (print) / ISBN 0742-3071
e-ISSN 1464-5491
Quellenangaben Volume: 13, Issue: 3, Pages: 359-364 Article Number: , Supplement: ,
Publisher Wiley
Reviewing status Peer reviewed
PubMed ID 3308565
Erfassungsdatum 1987-12-31